Improved left ventricular mass index in children after renal transplantation

Pediatric Nephrology

Volumn 23, Issue 9, 2008, Pages 1545-1550

  Becker Cohen, Rachel ^a,b   Nir, Amiram ^a,b   Ben Shalom, Efrat ^a,b   Rinat, Choni ^a,b   Feinstein, Sofia ^a   Farber, Benjamin ^a   Frishberg, Yaacov ^a,b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Hypertension; Left ventricular hypertrophy; Pediatric; Renal transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PROSPECTIVE STUDIES;

EID: 47749141818     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-0855-5     Document Type: Article

References (22)

1. McDonald SP, Craig JC (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654-2662
2. United States Renal Data System (2001) Excerpts from the USRDS 2001 annual report. Am J Kidney Dis 38 [Suppl 3]:S147-S158
3. Middleton RJ, Parfrey PS, Foley RN (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12:1079-1084
4. Becker-Cohen R, Nir A, Rinat C, Feinstein S, Algur N, Farber B, Frishberg Y (2006) Risk factors for cardiovascular disease in children and young adults after renal transplantation. Clin J Am Soc Nephrol 1:1284-1292
5. El-Husseini AA, Sheashaa HA, Hassan NA, El-Demerdash FM, Sobh MA, Ghoneim MA (2004) Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation. Pediatr Transplant 8:249-254
6. Matteuci MG, Giordano U, Calzolari A, Turchetta A, Santillli A, Rizzoni G (1999) Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int 56:1566-1570
7. Kitzmueller E, Vecsei A, Pichler J, Bohm M, Muller T, Vargha R, Csaicsich D, Aufricht C (2004) Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol 19:1385-1389
8. Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glassock BJ, Khoury PR, Daniels SR (2004) Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 43:721-726
9. Kessler M, Zannad F, Lehert P, Grunfeld JP, Thuilliez C, Leizorovicz A, Lechat P, FOSIDIAL investigators (2007) Predictors of cardiovascular events in patients with end-stage renal disease: An analysis from the Fosinopril in Dialysis study. Nephrol Dial Transplant 22:3573-3579
10. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
11. DeSimone G, Daniels SR, Devereux RB, Koren MJ, Meye RA, Laragh JH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251-1260
12. Khoury PR, Daniels SR, Gidding SS, Kimball TR (2004) Left ventricular mass index in children: What is the right index? J Am Soc Echocardiogr 17:555
13. Paoletti E, Cassottana P, Amidone M, Gherzi M, Rolla D, Cannella G (2007) ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: A randomized clinical trial. Am J Kidney Dis 50:133-142
14. Ferreira SR, Moises VA, Tavares A, Pacheo-Silva A (2002) Cardiovascular effects of successful renal transplantation: A 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation 74:1580-1587
15. Hernandez D, Lacalzada J, Salido E, Linares J, Barragan A, Lorenzo V, Higueras L, Martin B, Rodríguez A, Laynez I, Gonzalez-Posada JM, Torres A (2000) Regression of left ventricular hypertrophy by lisinopril after renal transplantation: Role of ACE gene polymorphism. Kidney Int 58:889-897
16. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR (1996) Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50:998-1006
17. Mitsnefes MM, Schwartz SM, Daniels SR, Kimball TR, Khoury P, Strife CF (2001) Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant 5:279-284
18. Kennedy DJ, Malhotra D, Shapiro JI (2006) Molecular insights into uremic cardiomyopathy: Cardiotonic steroids and Na/K ATPase signaling. Cell Mol Biol 52:3-14
19. Espino G, Denney J, Furlong T, Fitzsimmons W, Nash RA (2001) Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHD. Bone Marrow Transplant 28:1097-1103
20. Radermacher J, Meiners M, Bramlage C, Kilem V, Behrend M, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R (1998) Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporine A versus FK 506. Transpl Int 11:3-10
21. Ji SM, Li LS, Sha GZ, Chen JS, Liu ZH (2007) Conversion from cyclosporine to tacrolimus for chronic allograft nephrology. Transplant Proc 39:1402-1405
22. Pappas PA, Weppler D, Pinna AD, Rusconi P, Thompson JF, Jaffe JS, Tzakis AG (2000) Sirolimus in pediatric gastrointestinal transplantation: The use of sirolimus for pediatric transplant patients with tacrolimus-related cardiomyopathy. Pediatr Transplant 4:45-49